Ελευθερία Πετρουλάκη-Μέλλου

Ειδικός Παθολόγος -   2107470359, 6977080878

  • Methadone treatment: Hepatitis infection and liver

    Mavroides N,Douzenis A, Tsaklakidou D, Petroulaki E, Kokoris C4ο International Meetingof IGSC Organisation, Athens,December   1996
  • High compliance rate in Methadone maintenance HCV patiens with PegylatedInterferon a Plus Ribavirin than with Interferon a plus Ribavirin combination

    Dimitroulopoulos D., Petroulaki E., Manolakopoulos S., AnagnostouO., Tsaklakidou D., Xinopoulos D., Tsamakidis K., Tzourmakliotis D., Paraskevas E.20th  World Congress of Gastroenterology, Montreal Canada, 2005
  • Peginterferon /ribavirin Treatment Achieve Higher Compliance Rate inMethadone maintenance Chronic  HCVinfected Patiens Than with Interferon/ribavirin Combination

    Dimitris Dimitroulopoulos, Eleftheria Petroulaki, Spilios Manolakopoulos, Olga Anagnostou, Domna Tsaklakidou, Dimitris Xinopoulos, Klisthenis Tsamakidis, Dimitris Tzourmakliotis, Emmanouil Paraskevas106th Annual Meeting of the American Gastroenterological Association,Chicago USA,May 2005
  • AntiHCV treatment outcome in drug users is associatedwith buprenorfine use and adherence totreatment

    Anagnostou O1,Tsirogianni E1, Goulis I2, Moursellas A1,Kollia S1, Petroulaki E1, Dimitroulopoulos D3, Micha A1, Manolakopoulos S4
  • OKANA- Greek Organisation AgainstDrugs, 2Aristoteleion University Of Thessaloniki Medical School,

    3 Hellenic Anticancer Institute,"Saint Savvas" Hospital, 4 Athens University Medical School Latent TB infection among injection usersin methadone programs in Greece P.Katsaounou, E.Petroulaki, K.Kougianos, M.Gaggadi,G. Politis ATS May2006
  • Hepatitis C treatment for intravenous drugusers under substitution in real life

    O.Anagnostou, E.Tsirogianni, I.Goulis, S.Kollia, E.Petroulaki, D,Dimitroulopoulos, A.Micha, A.Moursellas, S. Manolakopoulos
  • OKANA- Greek Organisation Against Drugs, 2 Aristoteleion University Of Thessaloniki Medical School, 3 Hellenic Anticancer Institute, "Saint Savvas" Hospital,

    4 Athens University Medical School 1st International Symposium onHepatitis Care in Substance Users September 2009
  • ANTIHCVTREATMENT OUTCOME IN DRUG USERS IS ASSOCIATED WITH BUPRENORFINE USE ANDADHERENCE TO TREATMENT

    O.Anagnostou, E.Tsirogianni, Ι.Goulis, A.Moursellas, S.Kollia, E.Petroulaki, D.Dimitroulopoulos, K.Micha, S.Manolakopoulos
  • 2010 European Association for the Study of the Liver Treatment of chronic hepatitis C insubstitution programs: the Athens experience

    O.Anagnostou, E.Petroulaki, D.Dimitroulopoulos, A.Moursellas, I.Detsi, K.Alexakou, K.Kaliva, A.Tsantilas, M.Mela, S.Manolakopoulos, M.Malliori
  • OKANA- Greek Organisation Against Drugs, Gastroenterology Clinic of AntiCancer Hospital of Athens “Agios Savvas",

    Gastroenterology Clinic of PoliklinikiGeneral Hospital of Athens4, Athens University Medical School 3rdInternational Symposium on Hepatitis Care in Substance Users September 2013
  • 1